CRH (CRH) Stock Slides as Market Rises: Facts to Know Before You Trade

CRH (CRH) recently declined 1.52%, underperforming the broader market, despite a 9.33% monthly gain that lagged its sector. The building materials company is projected to report Q3 2025 revenue growth of 6.99% to $10.33 billion, though EPS is expected to dip 0.54% to $1.84, while full-year estimates show modest growth. Notably, CRH's consensus EPS projection has been revised 2.51% lower in the last 30 days, resulting in a Zacks Rank of #4 (Sell), reflecting negative analyst sentiment within a low-ranked industry. Despite trading at a forward P/E of 17.81 and a PEG ratio of 1.58, both discounts to its industry, the negative revisions and weak industry outlook suggest caution for investors.

Analysis

CRH Public Limited Company (CRH) is exhibiting conflicting signals, warranting a cautious outlook. The stock's recent 1.52% decline underperformed the broader market, and its one-month gain of 9.33% has lagged the Construction sector's 10.7% advance. Looking ahead, a disconnect emerges between top-line growth and profitability projections. While consensus estimates forecast a robust 6.99% year-over-year revenue increase to $10.33 billion for the upcoming quarter, the corresponding earnings per share (EPS) is expected to contract by 0.54% to $1.84. This near-term margin pressure is underscored by a significant negative indicator: the consensus EPS projection has been revised downward by 2.51% over the last 30 days. This revision has directly contributed to the stock's quantitative rating as a Zacks Rank #4 (Sell). Compounding these concerns, CRH operates within the Building Products - Miscellaneous industry, which ranks in the bottom 41% of over 250 industries, suggesting broad sectoral headwinds. Despite these bearish signals, the company's valuation appears relatively attractive, trading at a Forward P/E of 17.81 and a PEG ratio of 1.58, both of which represent discounts to their respective industry averages.

Key Decisions for Investors

• Investors should exercise caution, as the recent downward revisions to EPS estimates and the resulting Zacks Rank #4 (Sell) signal significant near-term risk that may outweigh the stock's monthly gains.
• Consider whether the stock's valuation discount, indicated by its below-average Forward P/E and PEG ratios, sufficiently compensates for the projected near-term earnings contraction and weak industry fundamentals.
• Closely monitor the upcoming August 6, 2025 earnings report for any deviation from the projected 0.54% EPS decline and for management's outlook on profitability trends and industry conditions.